doi: 10.1161/CIRCULATIONAHA.116.026324.
Epub 2016 Nov 13.
Imprecision: Limitations to Interpretation of a Large Randomized Clinical Trial
Affiliations
- PMID: 27840335
- PMCID: PMC5225045
- DOI: 10.1161/CIRCULATIONAHA.116.026324
Item in Clipboard
Imprecision: Limitations to Interpretation of a Large Randomized Clinical Trial
Circulation.
.
No abstract available
Keywords: anti-inflammatory agents, non-steroidal; arthritis; celecoxib; naproxen; risk.
Comment in
-
Letter by Brophy Regarding Article, "ImPRECISION: Limitations to Interpretation of a Large Randomized Clinical Trial".Circulation. 2017 May 23;135(21):e1052-e1053. doi: 10.1161/CIRCULATIONAHA.116.026414. Circulation. 2017. PMID: 28533323 No abstract available.
Similar articles
-
Therapy: Cardiovascular safety of celecoxib, naproxen and ibuprofen.Nat Rev Rheumatol. 2017 Mar;13(3):136-138. doi: 10.1038/nrrheum.2017.4. Epub 2017 Jan 27. Nat Rev Rheumatol. 2017. PMID: 28127041 No abstract available.
-
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.N Engl J Med. 2016 Dec 29;375(26):2519-29. doi: 10.1056/NEJMoa1611593. Epub 2016 Nov 13. N Engl J Med. 2016. PMID: 27959716 Clinical Trial.
-
[Cost-effectiveness analysis of celecoxib versus non-selective non-steroidal anti-inflammatory drug therapy for the treatment of osteoarthritis in Spain: A current perspective].Semergen. 2016 May-Jun;42(4):235-43. doi: 10.1016/j.semerg.2015.04.008. Epub 2015 May 23. Semergen. 2016. PMID: 26006311 Spanish.
-
Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.Clin Ther. 2005 Aug;27(8):1196-214. doi: 10.1016/j.clinthera.2005.07.019. Clin Ther. 2005. PMID: 16199245 Review.
-
Celecoxib safety revisited.Med Lett Drugs Ther. 2016 Dec 19;58(1510):159. Med Lett Drugs Ther. 2016. PMID: 27960193 Review. No abstract available.
Cited by
-
Plasma proteins and inflammatory dermatoses: proteome-wide Mendelian randomization and colocalization analyses.Arch Dermatol Res. 2024 Jul 1;316(7):443. doi: 10.1007/s00403-024-03191-x. Arch Dermatol Res. 2024. PMID: 38951247
-
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective.Biochem Pharmacol. 2020 Oct;180:114147. doi: 10.1016/j.bcp.2020.114147. Epub 2020 Jul 10. Biochem Pharmacol. 2020. PMID: 32653589 Free PMC article. Review.
-
Mammalian RNA switches: Molecular rheostats in gene regulation, disease, and medicine.Comput Struct Biotechnol J. 2019 Oct 24;17:1326-1338. doi: 10.1016/j.csbj.2019.10.001. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 31741723 Free PMC article. Review.
-
Consensi: Is it a conscientious combination?Br J Clin Pharmacol. 2019 May;85(5):1044. doi: 10.1111/bcp.13909. Epub 2019 Mar 21. Br J Clin Pharmacol. 2019. PMID: 30900286 Free PMC article. No abstract available.
-
Review of the top 5 cardiology studies of 2015-16.Can Pharm J (Ott). 2017 Sep 15;150(6):380-386. doi: 10.1177/1715163517729835. eCollection 2017 Nov-Dec. Can Pharm J (Ott). 2017. PMID: 29123597 Free PMC article. No abstract available.
References
-
- Becker MC, Wang TH, Wisniewski L, Wolski K, Libby P, Lüscher TF, Borer JS, Mascette AM, Husni ME, Solomon DH, Graham DY, Yeomans ND, Krum H, Ruschitzka F, Lincoff AM, Nissen SE, PRECISION Investigators Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Am Heart J. 2009;157:606–12. - PubMed
-
- Grosser T, Yu Y, FitzGerald GA. Emotion recollected in tranquility: lessons learned from the COX-2 saga. Annu Rev Med. 2010;61:17–33. - PubMed
-
- Coxib and traditional NSAID Trialists’ (CNT) Collaboration. Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J. Baigent C Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382:769–79. - PMC - PubMed
-
- Couzin J. Drug testing. Massive trial of Celebrex seeks to settle safety concerns. Science. 2005;310:1890–1. - PubMed
-
- MacDonald TM, Hawkey CJ, Ford I, McMurray JJ, Scheiman JM, Hallas J, Findlay E, Grobbee DE, Hobbs FD, Ralston SH, Reid DM, Walters MR, Webster J, Ruschitzka F, Ritchie LD, Perez-Gutthann S, Connolly E, Greenlaw N, Wilson A, Wei L, Mackenzie IS. Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT) Eur Heart J. 2016 Oct 4; pii: ehw387 [Epub ahead of print] - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
